PCAT19 interacts with HNRNPAB to activate a subset of cell-cycle genes associated with prostate cancer progression, thereby promoting prostate cancer tumor growth and metastasis (Hua et al., 2018). This evidence concerns the gene HNRNPAB and prostate cancer.